Controversial Hepatitis B Vaccine Trial Approved in Guinea-Bissau
A Danish-led trial in Guinea-Bissau will withhold a recommended hepatitis B vaccine dose from thousands of newborns.
The Chestnut Post Staff ·
A controversial hepatitis B vaccine trial in Guinea-Bissau received approval to proceed this week, according to The Guardian.
The study, led by Danish researchers, will withhold a recommended dose of the vaccine from thousands of newborns.
The Guardian describes the trial as central to the vaccine agenda of Robert F Kennedy Jr, the US secretary of health and human services and a longtime opponent of vaccines.
Originally reported by The Guardian. Read the full story at The Guardian
